Frequently Asked Questions (FAQs)
What is Alnylam Assist™?
Alnylam Assist™ includes Case Managers, Patient Education Liaisons, and Field Reimbursement Directors who provide support to patients prescribed Alnylam therapies. This support includes: verification of insurance benefits, coverage and reimbursement education, financial assistance support for eligible patients, and disease and product education. Each member of our team is assigned to specific geographic regions to work with patients, their caregivers, healthcare providers, and insurance companies to support patients throughout treatment on AMVUTTRA® (vutrisiran).
How do I enroll my patient in the Alnylam Assist™ program?
There are 3 ways to enroll your patient:
- Complete the electronic Start Form
•You will receive an auto-generated confirmation after submission to let you know we have received the Start Form and are initiating support services
•You and your patient will each receive a phone call from their Alnylam Case Manager within 2 business days of receipt
- Download the writable PDF version and fax the completed Start Form to Alnylam Assist™ at 833-256-2747
•You and your patient will receive a phone call from an Alnylam Case Manager within 2 business days of receipt
- Begin filling out the DocuSign form and DocuSign will send the form to your patient to complete
•Once you have finished your portion of the Start Form and provided an eSignature, it will be emailed to your patient so he or she can verify the information and fill out any remaining fields
•Both you and your patient will receive notification via email when the completed Start Form has been submitted to Alnylam Assist™
•An Alnylam Case Manager will reach out to you and your patient within 2 business days of receiving the completed Start Form
•For help submitting the DocuSign form, download our DocuSign Instructions.
See how to enroll your patients ›
Where can I find more materials about AMVUTTRA and Alnylam Assist™?
Support and educational materials about AMVUTTRA and Alnylam Assist™ can be found on this site. See additional materials ›
What support services does Alnylam Assist™ provide?
Alnylam Assist™ provides patients with product support services, including:
•Benefit verification for AMVUTTRA
•Education on the prior authorizations, claims, and appeals processes
•Financial assistance program enrollment for eligible patients*
•Information about hereditary ATTR (hATTR) amyloidosis and treatment with AMVUTTRA
•Ordering Product
Get more information about patient services ›
*Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.
Who makes up the Alnylam Assist™ team?
Case Managers are experienced in helping individuals get started on treatment and providing ongoing support. They will tailor their method of communication based on each individual's personal needs. Here’s how Case Managers provide additional patient support ›
Field Reimbursement Directors (FRDs) provide education about coverage, coding, and reimbursement for AMVUTTRA®. FRDs are knowledgeable about AMVUTTRA billing and coding requirements. Here’s more information about the FRD role ›
Patient Education Liaisons (PELs)* have backgrounds in nursing, and are experienced in educating individuals and their families about matters related to hATTR amyloidosis. PELs can help patients in a variety of ways, including providing disease and product education, connecting patients to additional resources, and answering questions about treatment with AMVUTTRA. Get acquainted with members of the PEL team ›
•The purpose of Alnylam Patient Education Liaisons (PELs) is to provide education to patients, their families, and caregivers
•PELs are employees of Alnylam Pharmaceuticals and do not provide medical advice
•All diagnosis and treatment decisions should be made by the treating physician and their patients
Enrolling Your Patients
Together with your patient
(in office)
Initiate then send to patient
(via email)
